Market Cap : 7.21 B | Enterprise Value : 6.16 B | PE Ratio : | PB Ratio : 8.49 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF margin is calculated as Free Cash Flow divided by its Revenue. Ionis Pharmaceuticals's Free Cash Flow for the three months ended in Dec. 2020 was $91.1 Mil. Ionis Pharmaceuticals's Revenue for the three months ended in Dec. 2020 was $290.3 Mil. Therefore, Ionis Pharmaceuticals's FCF margin for the quarter that ended in Dec. 2020 was 31.38%.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Ionis Pharmaceuticals's FCF Margin % falls into.
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Ionis Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2020 is calculated as
FCF Margin | = | Free Cash Flow (A: Dec. 2020 ) | / | Revenue (A: Dec. 2020 ) |
= | -5.156 | / | 729.264 | |
= | -0.71 % |
Ionis Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2020 is calculated as
FCF Margin | = | Free Cash Flow (Q: Dec. 2020 ) | / | Revenue (Q: Dec. 2020 ) |
= | 91.103 | / | 290.281 | |
= | 31.38 % |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline